NERV - Minerva Neurosciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
50,235
26,052
82,981
14,284
Short Term Investments
37,762
102,109
0
17,921
Total Cash
87,997
128,161
82,981
32,205
Net Receivables
-
-
-
-
Inventory
-
-
-
-
Other Current Assets
-
0
0
0
Total Current Assets
90,018
129,540
83,864
33,481
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
33
-
-
-
Accumulated Depreciation
-
-
-
-
Net property, plant and equipment
33
51
10
26
Equity and other investments
0
5,023
-
-
Goodwill
14,869
14,869
14,869
14,869
Intangible Assets
34,200
34,200
34,200
34,200
Other long-term assets
15
15
0
0
Total non-current assets
49,118
54,158
49,079
49,096
Total Assets
139,136
183,699
132,943
82,576
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
3,963
4,854
1,435
Accounts Payable
1,800
1,436
1,468
1,361
Taxes payable
-
-
-
-
Accrued liabilities
1,810
1,434
3,364
1,800
Deferred revenues
-
-
-
-
Other Current Liabilities
-
0
0
0
Total Current Liabilities
3,609
6,838
9,686
5,320
Non-current liabilities
Long Term Debt
-
0
3,841
8,503
Deferred taxes liabilities
4,057
4,057
13,434
13,434
Deferred revenues
41,176
41,176
-
-
Other long-term liabilities
29
30
0
0
Total non-current liabilities
45,262
45,263
17,275
21,937
Total Liabilities
48,871
52,101
26,961
27,257
Stockholders' Equity
Common Stock
4
4
4
2
Retained Earnings
-214,553
-164,381
-132,858
-101,813
Accumulated other comprehensive income
-
-
-
-
Total stockholders' equity
90,265
131,597
105,982
55,320
Total liabilities and stockholders' equity
139,136
183,699
132,943
82,576